Walleye Trading LLC Iovance Biotherapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $193,545 - $445,485	25,500 New	25,500 $377,000
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $22,512 - $38,052	4,200 New	4,200 $29,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $232,744 - $359,080	-18,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $263,145 - $439,317	15,900 Added 548.28%	18,800 $359,000
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $972,730 - $1.27 Million	-47,800 Reduced 94.28%	2,900 $72,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $679,327 - $1.38 Million	41,600 Added 457.14%	50,700 $1.32 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $260,897 - $478,569	9,100 New	9,100 $288,000
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $544,200 - $820,000	-20,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $390,800 - $777,000	20,000 New	20,000 $599,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.38B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.